IPCA Laboratories Limited (IPCALAB):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:IPCA Laboratories Limited (IPCALAB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81848FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

IPCA Laboratories Limited (IPCA) is a generic pharmaceutical company. It undertakes the manufacturing and distribution of active pharmaceutical ingredients (APIs) and formulations. The company’s APIs products include Atenolol, Chloroquine Phosphate, Furosemide, Hydroxychloroquine Sulphate, Metoprolol Succinate, Metoprolol Tartrate and Pyrantel Salts. Its products find application in the therapeutic areas of acne, antibiotics, brain disease, malaria, mental illness, fever, pain, urinary disease, stomach ailments, heart ailment, and steroid, among others. IPCA offers products in various formulations such as oral solids and liquids, dry powders for suspension, and injectables. It markets products under brand names such as Zerodol, Lariago, HCQS, Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid, and Folitrax, among others. Some of the company’s key clients include global pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, Merck, Roche and Sanofi Aventis. It operates through its subsidiaries and markets products in Africa, Asia, Australia, Europe and the US. IPCA is headquartered in Mumbai, Maharashtra, India.

IPCA Laboratories Limited Key Recent Developments

Nov 23, 2013: Ipca Laboratories Wins Case Against Anrose Pharma Over False Representation Of Zerodol
Oct 24, 2013: Ipca Laboratories Q2 FY14 Results
Jul 30, 2013: Ipca Laboratories Q1 FY14 Results
May 30, 2013: Ipca Laboratories FY 2012-13 Standalone Audited Financial Results
Mar 31, 2013: Ipca Laboratories Q4 FY12 Financial Results

This comprehensive SWOT profile of IPCA Laboratories Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of IPCA Laboratories Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

IPCA Laboratories Limited – Key Information
IPCA Laboratories Limited – Overview
IPCA Laboratories Limited – Key Employees
IPCA Laboratories Limited – Key Employee Biographies
IPCA Laboratories Limited – Key Operational Heads
IPCA Laboratories Limited – Major Products and Services
IPCA Laboratories Limited – History
IPCA Laboratories Limited – Company Statement
IPCA Laboratories Limited – Locations And Subsidiaries
IPCA Laboratories Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

IPCA Laboratories Limited – Business Description
IPCA Laboratories Limited – Corporate Strategy
IPCA Laboratories Limited – SWOT Analysis
SWOT Analysis – Overview
IPCA Laboratories Limited – Strengths
IPCA Laboratories Limited – Weaknesses
IPCA Laboratories Limited – Opportunities
IPCA Laboratories Limited – Threats
IPCA Laboratories Limited – Key Competitors

Section 3 – Company Financial Performance Charts

IPCA Laboratories Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

IPCA Laboratories Limited, Key Information
IPCA Laboratories Limited, Key Ratios
IPCA Laboratories Limited, Share Data
IPCA Laboratories Limited, Major Products and Services
IPCA Laboratories Limited, History
IPCA Laboratories Limited, Key Employees
IPCA Laboratories Limited, Key Employee Biographies
IPCA Laboratories Limited, Key Operational Heads
IPCA Laboratories Limited, Other Locations
IPCA Laboratories Limited, Subsidiaries
IPCA Laboratories Limited, Key Manufacturing facilities
IPCA Laboratories Limited, Key Competitors
IPCA Laboratories Limited, SWOT Analysis
IPCA Laboratories Limited, Ratios based on current share price
IPCA Laboratories Limited, Annual Ratios
IPCA Laboratories Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

IPCA Laboratories Limited, Performance Chart
IPCA Laboratories Limited, Ratio Charts

★海外企業調査レポート[IPCA Laboratories Limited (IPCALAB):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QinetiQ Group PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' QinetiQ Group PLC Mergers and A …
  • ION Geophysical Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ION Geophysical Corporation Mer …
  • Skye Bank Plc:企業の戦略・SWOT・財務分析
    SummarySkye Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Groupe Guillin SA:企業の戦略・SWOT・財務分析
    SummaryGroupe Guillin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • SNC-Lavalin Group Inc (SNC)-石油・ガス分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Vita 34 International AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vita 34 International AG Merger …
  • Perennial International Limited (725):企業の財務及び戦略的SWOT分析
    Summary Perennial International Limited (Perennial) is an electrical equipment manufacturer that designs and trades cables and wire products. The company offers products such as plastic resins, low voltage cables, tooling and molding, wire harnesses, and power cords. It manufactures products for dif …
  • Bayer HealthCare Pharmaceuticals:企業のM&A・提携動向(医療機器分野)
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company provides prescript …
  • Malaysia Smelting Corporation Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Malaysia Smelting Corporation B …
  • Valero L.P.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Valero L.P. Mergers and Acquisi …
  • Chimerix Inc (CMRX):企業財務及び戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a biopharmaceutical company that discovers, develops and commercializes novel, oral antiviral therapeutics. The company’s brincidofovir is an oral nucleotide analog to treat dsDNA viruses, cytomegalovirus, adenovirus, BK virus and herpes simplex viruses. It also de …
  • Calibre Group Ltd:企業の戦略・SWOT・財務分析
    SummaryCalibre Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Citadel, LLC (formerly known as Citadel Investment Group, LLC):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Citadel, LLC (formerly known as …
  • Deepak Fertilisers and Petrochemicals Corporation Limited (DEEPAKFERT):企業の財務及び戦略的SWOT分析
    Summary Deepak Fertilisers and Petrochemicals Corporation Limited (DFPC) is a chemical company that offers industrial chemical and fertilizers. The company produces and markets industrial chemicals, ammonia, mining chemicals, and fertilizers. Its industrial chemicals include iso propyl alcohol, dilu …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • EuroSibEnergo PLC:企業のM&A・提携動向(エネルギー分野)
    Summary EuroSibEnergo PLC (EuroSibEnergo) is a privately held energy company and producer of hydroelectric power. EuroSibEnergo generates, transmits and distributes electricity. It has vertically integrated coal-power operations, from extraction of coal to distribution, facilitating low cost operati …
  • O’Learys Trademark AB:企業の戦略・SWOT・財務分析
    SummaryO'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Foot Locker, Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "Foot Locker, Inc. : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company …
  • LPL Financial Holdings Inc.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "LPL Financial Holdings Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆